Alkem Laboratories partners with Sonnet BioTherapeutics to develop and commercialize SON-080, a potential treatment for ...

Mumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to ...

India is grappling with a substantial burden of diabetes-related complications with diabetic peripheral neuropathy being a ...

Under the licensing agreement, Alkem will carry out the clinical development of 'SON-080' in India with support from Sonnet ...

Advantage Neuropathy specializes in providing leading edge pain therapy and treatment that is an FDA cleared solution.

Sonnet BioTherapeutics Holdings, Inc. (SONN) announced Wednesday that it has entered into a licensing agreement with Alkem ...

Peripheral neuropathy and hearing loss are both common in older patients and seem to be independently and additively related to premature mortality.

Dr. Lucas Brown, DAOM, LAc with Rosedale Acupuncture and Wellness spoke with Studio 512 about offering help to people who are experiencing peripheral neuropathy as a side effect of chemotherapy ...

Dr. Brian Rich states that neuropathy comes from a lot of different causes. One of the most common causes is diabetic peripheral neuropathy from uncontrolled diabetes and patients a lot of times, ...

Sonnet BioTherapeutics Holdings ( (SONN) ) has issued an update. Sonnet BioTherapeutics Holdings, Inc. has partnered with ...

SON-080 is a recombinant human Interleukin-6 (rhIL-6) aimed at treating diabetic peripheral neuropathy ... the unmet medical needs for neuropathy treatments in India. In other recent news ...

Those who suffer from peripheral neuropathy know it doesn’t manifest ... which is great for a custom treatment. It also has acupressure points which can be helpful with providing added pain ...